Form 8-K - Current report:
SEC Accession No. 0001437749-15-017600
Filing Date
2015-09-22
Accepted
2015-09-22 13:57:05
Documents
3
Period of Report
2015-09-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bota20150922_8k.htm 8-K 23259
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 18460
3 ex99-1img002.gif GRAPHIC 4861
  Complete submission text file 0001437749-15-017600.txt   50070
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 151119085
SIC: 2836 Biological Products, (No Diagnostic Substances)